Skip to main navigation
  • Home
  • Synthetic Biology
    • The History of Synthetic Biology
  • Living Medicines
    • Designing Synthetic Bioticâ„¢ Medicines
  • Pipeline + Programs
  • For Patients
  • Our People
    • Leadership
    • Board of Directors
    • Founders and Advisors
    • Join Us
  • Investors + Media
    • Company Overview
    • News & Events
    • Presentations & Publications
    • Stock Information
    • Corporate Governance
    • Financials
    • Investor Resources
explore the
possibilities

Synlogic Therapeutics

Investor Relations

SEC Filing Details

  • Home
  • Synthetic Biology
    • The History of Synthetic Biology
  • Living Medicines
    • Designing Synthetic Bioticâ„¢ Medicines
  • Pipeline + Programs
  • For Patients
  • Our People
    • Leadership
    • Board of Directors
    • Founders and Advisors
    • Join Us
  • Investors + Media
    • Company Overview
    • News & Events
    • Presentations & Publications
    • Stock Information
    • Corporate Governance
    • Financials
    • Investor Resources

SEC Filing Details

Document Details

Form
4
Filing Date
Mar 12, 2021
Document Date
Mar 10, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Synlogic
Issuer
Synlogic, Inc.
Filer
AWAD ANTOINE

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
  • Email Alerts
  • Contact IR
  • RSS Feeds
  • Print Page
  • Email Page

Synlogic Therapeutics

Contact

Synlogic

301 Binney St #402
Cambridge, MA 02142

info@synlogictx.com
(617) 401-9975

  • Twitter
  • LinkedIn

Privacy and Terms

© 2018 Synlogic
Privacy Policy